Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose intravenous vitamin C for post-cardiac arrest shock
2022-500717-64-00Phase 2Completed
- Sponsor
- Centre Hospitalier de Béthune-Beuvry
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ascorbic acid in cardiac arrest (SCA) (2 arms), sponsored by Centre Hospitalier de Béthune-Beuvry. Primary endpoint: Cumulative incidence of weaning from vasopressors at day 3 after out-of-hospital cardiac arrest. Started Dec 2023; status: completed.
02
Drugs
ascorbic acid
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2022-500717-64-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500717-64-00.